Innate Pharma SA
1.6660
07-4月-25 11:00:38
15 分の遅延
株式
-0.0600
-3.48%
本日の幅
1.3520 - 1.6860
ISIN
FR0010331421
ソース
Cboe
-
Innate Pharma to Hold its Annual General Meeting of Shareholders on May 28, 2021
21 4 2021 01:00:00 提供 Nasdaq GlobeNewswire
-
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF APRIL 1, 2021
19 4 2021 01:00:00 提供 Nasdaq GlobeNewswire
-
Innate Pharma reports Full Year 2020 financial results and business update
18 3 2021 02:00:00 提供 Nasdaq GlobeNewswire
-
Innate Pharma announces conference call and webcast for Full Year 2020 financial results
16 3 2021 02:00:00 提供 Nasdaq GlobeNewswire
-
Number of shares and voting rights of Innate Pharma as of February 1, 2021
24 2 2021 01:00:00 提供 Nasdaq GlobeNewswire
-
Innate Pharma to participate in the 10th Annual SVB Leerink Global Healthcare Conference
17 2 2021 01:00:00 提供 Nasdaq GlobeNewswire
-
Innate Pharma advances lacutamab clinical development program
09 2 2021 01:00:00 提供 Nasdaq GlobeNewswire
-
03 2 2021 01:00:00 提供 Nasdaq GlobeNewswire
-
Innate's first NK cell engager selected by Sanofi as drug candidate for development
05 1 2021 01:00:00 提供 Nasdaq GlobeNewswire
-
Innate Pharma to participate in upcoming investor conferences
04 1 2021 01:00:00 提供 Nasdaq GlobeNewswire